-
NVision Quantum Technologies
Created in 2015
-
-
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups -
Social networks
8,344 8,344 -
Activities
-
Technologies
-
Entity types
-
Location
Wolfgang-Paul-Straße 2, 89081 Ulm, Germany
Ulm
Germany
-
Employees
Scale: 51-200
Estimated: 141
-
Engaged catalyst
9
0 0 -
Added in Motherbase
3 years, 8 months ago
-
Value proposition
NVision is pioneering a new generation of quantum systems designed to bring quantum computing and quantum sensing out of the lab and into the real world, transforming how diseases are understood, detected, and treated.
We engineer and control the quantum properties of organic molecules, integrating molecular design and quantum hardware into scalable products.
Our POLARIS platform uses quantum-based hyperpolarization to enable real-time metabolic MRI with more than 10,000x signal enhancement, supporting non-invasive, early-stage disease detection and treatment monitoring.
We also introduced PIQC (Photonic Integrated Quantum Circuits), a fundamentally new quantum computing architecture that combines molecular qubits with photonic integrated circuits to enable scalable biological modeling and next generation drug discovery.
At NVision, we see these technologies converging into a new “compute and validate” paradigm, where quantum systems are used both to design therapies and to measure their biological impact.
MRI, NMR, Quantum Optics, Quantum Computing, Quantum Sensing, Photonics, Metabolic MRI, Hyperpolarized MRI, Molecular Imaging, Drug Discovery, Photonic Integrated Quantum Circuits, Healthcare Technology, and Deep Tech
-
Home | NVision
NVision Quantum leads the transformation in quantum computing and quantum-enhanced sensing by mastering quantum spin control to accelerate scientific discovery.
https://www.nvision-quantum.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing (Auto) |
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing (Auto) |
Other
13 Jan 2026 |
|
|
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care (Auto) |
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care (Auto) |
Other
13 Jan 2026 |
|
|
McKinsey & Company
Consulting, Business Consulting and Services (Auto) |
McKinsey & Company
Consulting, Business Consulting and Services (Auto) |
Other
11 Nov 2025 |
|
|
CEA
Research, Research Services (Auto) |
CEA
Research, Research Services (Auto) |
Other
11 Nov 2025 |
|
|
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology (Auto) |
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology (Auto) |
Other
20 Nov 2025 |
|
|
European Innovation Council and SMEs Executive Agency (EISMEA)
Startup accelerator & VC, Government Administration (Auto) |
European Innovation Council and SMEs Executive Agency (EISMEA)
Startup accelerator & VC, Government Administration (Auto) |
Other
28 Jul 2023 |
|
|
CNRS
Research, Research Services (Auto) |
CNRS
Research, Research Services (Auto) |
Other
30 Jun 2024 |
|
|
Startup Europe
Startup accelerator & VC, Public Policy Offices (Auto) |
Startup Europe
Startup accelerator & VC, Public Policy Offices (Auto) |
Other
16 Nov 2022 |
|
|
Eurostat
European Union, Government Administration (Auto) |
Eurostat
European Union, Government Administration (Auto) |
Other
30 Jun 2025 |
|
|